OCREVUS (ocrelizumab)

Pages: [1] 2 3 ... 5

Subject / Started by	Replies / Views	Last post
(Abst.) Recurrence of disease activity after ocrelizumab discontinuation in MS (Abst.) Recurrence of disease activity after ocrelizumab discontinuation in MS agate · October 07, 2024, 09:25:39 am This was a small study but it indicates that some people might have worsening MS if they stop taking Ocrevus....From PubMed (Oct... 1 Replies · 512 Views Started by agate	1 Replies 512 Views	January 21, 2026, 08:53:17 pm by agate
(Abst.) Cardiogenic shock after ocrelizumab infusion in RRMS (MS Journal) (Abst.) Cardiogenic shock after ocrelizumab infusion in RRMS (MS Journal) agate · January 01, 2026, 09:55:32 pm This article was "restricted access" but through an institutional affiliation (University of Chicago alumni access) I was able t... 1 Replies · 13 Views Started by agate	1 Replies 13 Views	January 02, 2026, 09:29:10 pm by agate
Severe late-onset neutropenia in a patient with MS treated with ocrelizumab Severe late-onset neutropenia in a patient with MS treated with ocrelizumab agate · December 27, 2025, 09:15:05 pm From Cureus (December 18, 2025): Severe late-onset neutropenia in a patient with multiple sclerosis treated with ocrelizumab 0 Replies · 6 Views Started by agate	0 Replies 6 Views	December 27, 2025, 09:15:05 pm by agate
(ECTRIMS) Ocrelizumab may double serious infection risk in MS (ECTRIMS) Ocrelizumab may double serious infection risk in MS agate · October 26, 2025, 04:06:15 pm From MedPage Today (September 28, 2025)--"Ocrelizumab may double serious infection risk in MS":https://www.medpagetoday.com/meet... 0 Replies · 24 Views Started by agate	0 Replies 24 Views	October 26, 2025, 04:06:15 pm by agate
(ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 and older... (ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 and older... agate · March 21, 2025, 09:14:34 pm Presented at the annual ACTRIMS forum for 2025, "Multiple sclerosis patients treated with ocrelizumab, aged 70 and older: A ret... 1 Replies · 147 Views Started by agate	1 Replies 147 Views	April 27, 2025, 03:01:48 pm by agate
Genentech updates Phase 3 Ocrevus high-dose study in people w/relapsing MS Genentech updates Phase 3 Ocrevus high-dose study in people w/relapsing MS agate · April 03, 2025, 10:07:08 am From BusinessWire.com (April 2, 2025)--"Genentech Provides Update on Phase III Ocrevus High-Dose Study in People with Relapsing ... 0 Replies · 69 Views Started by agate	0 Replies 69 Views	April 03, 2025, 10:07:08 am by agate
Ocrevus biosimilar (Xacrel) shows equivalent efficacy as MS treatment Ocrevus biosimilar (Xacrel) shows equivalent efficacy as MS treatment agate · December 02, 2024, 08:43:36 pm From the American Journal of Managed Care/Center for Biosimilars (November 26, 2024)"[Ocrelizumab] biosimilar shows equivalent e... 0 Replies · 110 Views Started by agate	0 Replies 110 Views	December 02, 2024, 08:43:36 pm by agate
(Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus... (Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus... agate · October 22, 2024, 09:11:19 pm From Nature (October 22, 2024)--"Evaluating efficacy and safety of ocrelizumab (Xacrel) compared to the originator (Ocrevus) in ... 0 Replies · 327 Views Started by agate	0 Replies 327 Views	October 22, 2024, 09:11:19 pm by agate
(Abst.) The wearing-off phenomenon of ocrelizumab in patients w/MS (Abst.) The wearing-off phenomenon of ocrelizumab in patients w/MS agate · February 16, 2022, 08:41:56 pm From PubMed (February 16, 2022)--"The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis":https://pubmed.... 1 Replies · 528 Views Started by agate	1 Replies 528 Views	October 20, 2024, 11:21:41 am by agate
Subcutaneous Ocrevus Zunovo has FDA approval Subcutaneous Ocrevus Zunovo has FDA approval agate · September 14, 2024, 04:58:02 pm From NeurologyLive (September 12, 2024)--"FDA Approves Subcutaneous Formulation of Ocrelizumab for Relapsing and Progressive Mul... 0 Replies · 402 Views Started by agate	0 Replies 402 Views	September 14, 2024, 04:58:02 pm by agate
(Abst.) Ocrelizumab in people w/primary progressive MS... (Abst.) Ocrelizumab in people w/primary progressive MS... agate · July 27, 2024, 03:23:45 pm From PubMed (July 27, 2024)--"Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric stud... 0 Replies · 341 Views Started by agate	0 Replies 341 Views	July 27, 2024, 03:23:45 pm by agate
Subcutaneous Ocrevus gets EU approval Subcutaneous Ocrevus gets EU approval agate · June 25, 2024, 08:57:31 pm From Morningstar (June 24, 2024)--"Roche's Multiple Sclerosis Injection Gets EU Approval":https://www.morningstar.com/news/dow-j... 1 Replies · 382 Views Started by agate	1 Replies 382 Views	July 12, 2024, 08:37:14 pm by agate
Ocrelizumab-associated enteritis in patients w/MS: An emerging safety issue Ocrelizumab-associated enteritis in patients w/MS: An emerging safety issue agate · July 12, 2024, 04:01:22 pm From Journal of Neurology (July 11, 2024)--"Ocrelizumab-associated enteritis in patients with multiple sclerosis: An emerging sa... 0 Replies · 357 Views Started by agate	0 Replies 357 Views	July 12, 2024, 04:01:22 pm by agate
(Abst.) Ocrelizumab in highly disabled progressive MS patients (Abst.) Ocrelizumab in highly disabled progressive MS patients agate · January 07, 2024, 08:02:50 am From PubMed (January 7, 2024)--"Ocrelizumab in highly disabled progressive multiple sclerosis patients":https://pubmed.ncbi.nlm.... 0 Replies · 305 Views Started by agate	0 Replies 305 Views	January 07, 2024, 08:02:50 am by agate
(Abst.) Neutropenia complications from ocrelizumab and rituximab treatment (Abst.) Neutropenia complications from ocrelizumab and rituximab treatment agate · December 04, 2023, 11:04:57 am From PubMed (December 4, 2023)--"Neutropaenia complications from Ocrelizumab and Rituximab treatment":https://pubmed.ncbi.nlm.ni... 0 Replies · 297 Views Started by agate	0 Replies 297 Views	December 04, 2023, 11:04:57 am by agate
(JAMA) Rituximab vs ocrelizumab in RRMS (JAMA) Rituximab vs ocrelizumab in RRMS agate · June 12, 2023, 10:09:55 am From JAMA Neurology (June 12, 2023)--"Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis": https://bit.ly/43BuNIb 4 Replies · 3224 Views Started by agate	4 Replies 3224 Views	November 27, 2023, 04:18:36 pm by agate
(ECTRIMS) Ocrevus benefit confirmed in patients over 60 with MS (ECTRIMS) Ocrevus benefit confirmed in patients over 60 with MS agate · October 13, 2023, 08:41:51 pm From MedPage Today (October 12, 2023)--"Ocrelizumab benefit confirmed in older patients with MS"--a report from the ECTRIMS conf... 0 Replies · 398 Views Started by agate	0 Replies 398 Views	October 13, 2023, 08:41:51 pm by agate
Phase III trial: Ocrevus twice yearly w/10-minute subcutaneous injection Phase III trial: Ocrevus twice yearly w/10-minute subcutaneous injection agate · July 13, 2023, 09:52:06 am Maybe Ocrevus will be available as a twice-yearly 10-minute subcutaneous injection. It's not clear whether the injection can be ... 3 Replies · 579 Views Started by agate	3 Replies 579 Views	October 12, 2023, 04:35:59 pm by agate
(Abst.) Severe U. urealyticum infection in patient w/ocrelizumab-induced hypogammaglobulinemia" (Abst.) Severe U. urealyticum infection in patient w/ocrelizumab-induced hypogammaglobulinemia" agate · September 28, 2023, 09:38:13 pm From PubMed (September 27, 2023)--"Severe Ureaplasma urealyticum infection in a patient with ocrelizumab-induced hypogammaglobul... 0 Replies · 278 Views Started by agate	0 Replies 278 Views	September 28, 2023, 09:38:13 pm by agate
(ACTRIMS2023) Delays in Ocrevus infusions not tied to greater MS activity (ACTRIMS2023) Delays in Ocrevus infusions not tied to greater MS activity agate · March 06, 2023, 09:29:50 pm From Multiple Sclerosis News Today (March 6, 2023)--"ACTRIMS 2023: Delays in Ocrevus infusions not tied to greater MS activity":... 0 Replies · 161 Views Started by agate	0 Replies 161 Views	March 06, 2023, 09:29:50 pm by agate

Pages: [1] 2 3 ... 5

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

MS Speaks